Safely Returning to Work During the Pandemic

CHICAGO, May 18, 2020 /PRNewswire/ — Most people will acquire the novel coronavirus before a vaccine is available. A business that does not require screening its staff for symptoms – an essential aspect of infection control – may become a transmission hotspot. When many employees get sick at once, operations are disrupted, individuals become resentful, and wrongdoing claims increase. Offices located in urban areas are at a higher risk since public transit increases spread. The solution is daily employee health assessments, which will need to persist for a year or longer.

Auscura leverages technology to keep COVID-19 out of the workplace. SmartContact™ is its communication platform that allows employees to relay symptoms and high-risk activities before coming to work. It eliminates human errors, creates workflow efficiencies, and complies with CDC and OSHA recommendations. Employees are linked to educational resources and company policies that address infection control.

According to Dr. Tom Scaletta, CEO of Auscura, and a practicing emergency physician, “Daily symptom surveillance is integral to workplace safety.” He maintains, “Checking temperatures at an entrance creates bottlenecks, requires the expense of screeners, and is a clinically-flawed strategy. Even when I admit patients to the hospital with COVID-19 pneumonia, less than a third have a fever at triage. I recommend self-checks for fever using an oral thermometer, which is more accurate than infrared, forehead devices. We need to know if there are symptoms before someone leaves home, so no infection is passed along during a commute.”

SmartContact applies the CDC’s return to work decision tree to automate patient follow-up using a text message link to a secure survey. Patient-initiated surveillance saves hours of work. Alerts are pushed to company administrators when an employee reports symptoms or exposure risk, and the data can be quickly retrieved whenever needed.

Auscura is a leader in automating healthcare communication. Its SmartContact™ platform facilitates healthcare messaging for a diverse set of use cases in ways that are effective, affordable, and easy to implement. Auscura’s founder, Tom Scaletta, MD, was a software programmer before entering medical school. He is now a practicing emergency physician who is board-certified in emergency medicine and clinical informatics and oversees two Chicago-area emergency departments.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

 

View original content:http://www.prnewswire.com/news-releases/safely-returning-to-work-during-the-pandemic-301060578.html

SOURCE Auscura

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

6 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

1 day ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

1 day ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

1 day ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

1 day ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

1 day ago